Welcome Benjamin R. Lin, MD!
Texas Retina is pleased to welcome board-certified ophthalmologist and retina specialist Benjamin R. Lin, MD, to our practice on September 2, 2025. Serving patients in our Dallas Main, Dallas North and Plano
read more
Why Your Appointment May Take Longer Than Anticipated
We often have patients and family members ask why they have to wait or why their appointment is taking so long, especially if they see other patients called back before them. We
read more
Dr. Abbey Delivered On-Demand Presentation About the PHOTON DME Study for ASRS 2025 Meeting
On behalf of the PHOTON study investigators, Texas Retina’s Ashkan M. Abbey, MD, delivered an on-demand presentation titled “Differential Anatomic Response to Aflibercept 8 mg vs 2 mg During Matched Dosing Phase
read more
Dr. Nikisha Kothari Selected as “One to Watch” in Retina Today
Texas Retina’s Dr. Nikisha Kothari has been selected as a “One to Watch” in the July/August issue of Retina Today. This feature highlights individuals identified as future leaders in the field of
read more
Initial Results of Phase Ib LOTUS Clinical Trial on Potential New Diabetic Macular Edema Treatment Released
On June 9, 2025, Eluminex Biosciences Limited, a clinical-stage protein therapeutics company, announced positive topline safety, tolerability, and pharmacodynamic data from the multicenter LOTUS Part 1 clinical trial of EB-105 in patients
read more Dr. Abbey Discusses How Vorolanib Could Shift the Treatment Approach for Diabetic Macular Edema in New Retinal Physician Article
Texas Retina’s Ashkan M. Abbey, MD, served as a principal site investigator for the Phase II VERONA clinical trial evaluating the efficacy and safety of the vorolanib intravitreal insert (EYP-1901) in diabetic
read more
When Should You See a Retina Specialist?
Your ophthalmologist or optometrist can monitor your vision, prescribe glasses and contact lenses, and diagnose, treat and prevent a number of eye diseases. However, for some eye conditions, your eye doctor may
read more
Can Ozempic Affect Your Eyes or Vision?
Initially approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar and treat type 2 diabetes, semaglutide (brand names Ozempic, Wegovy and Rybelsus) has also emerged as a
read more
Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences,
read more
Dr. Wang Presented Study Results of New Wet AMD Treatment Approach at the ARVO 2025 Meeting
On May 9, 2025, Texas Retina’s Robert C. Wang, MD, presented “Top Line Results from ODYSSEY: A Phase IIb Study of Suprachoroidally Administered CLS-AX in Participants with Neovascular Age-related Macular Degeneration” at
read more